INTERogating Cancer for Etiology, Prevention and Therapy Navigation

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This study is being done to identify markers and causes of cancer by analyzing patient's DNA (i.e., genetic material), RNA, plasma, tissues, or other samples that could be informative for patients with cancer. Cancer genetic testing is a series of tests that finds specific changes in cancer cells and normal cells in the body. Researchers may request to access these data as they explore how to better prevent, screen, or treat cancer. This study is also being done to create a biobank (library) of samples and information to learn more about treating cancer. Discovery of genetic variants in patients with cancer could result in opportunities for cancer prevention, earlier diagnosis or better therapy for cancer.

Eligibility criteria

Qualifiers

Has Mayo Clinic medical record number

Confirmed cancer diagnosis

Germline and/or somatic tumor/blood testing has been ordered by the clinical provider (or clinical delegate)

Participant aware of cancer diagnosis

Disqualifiers

Individuals who have situations that would limit compliance with the study requirements

Institutionalized (i.e. Federal Medical Prison)

Individuals who have situations that would limit compliance with the study requirements

Institutionalized (i.e. Federal Medical Prison)

Trial design

Treatments tested in this trial

  • Pan-genomic Testing

Treatment groups

500 Participants
are divided into 2 treatment groups

Sponsors and collaborators